Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea · Delayed Price · Currency is KRW 6,610.00
+60.00 (0.92%)
At close: May 8, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 91.23 billion as of May 11, 2026. Its market cap has decreased by -3.56% in one year.
Market Cap
91.23B
Enterprise Value
157.18B
Revenue
202.40B
Ranking
n/a
PE Ratio
5.98
Stock Price
6,610.00
Market Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 91.23B, an increase of 600.04%. That is a compound annual growth rate of 8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 91.23B | -1.07% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KOREA PHARMA | 120.85B |
| H.PIO | 114.13B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 112.61B |
| Pharos iBio | 107.32B |
| Polaris AI Pharma | 100.69B |
| Sam-A Pharm. | 98.75B |
| Ahn-Gook Pharmaceutical | 90.81B |
| Sinsin Pharmaceutical | 84.50B |